PharmaPrint Joins with Chinese Firm

PharmaPrint Joins with Chinese Firm

IRVINE, Calif.--PharmaPrint Inc., which develops health products from naturalplant extracts, completed a binding legal agreement with ShenZhen ZeGu VentureCapital Co. Ltd. ShenZhen ZeGu is a wholly-owned subsidiary of China NewIndustries Investment Co. Ltd. The agreement gives PharmaPrint 51 percent of thenew entity, and it will transfer the use rights of its technology, offertechnical assistance and grant exclusive license for use of PharmaPrint tradesecrets, patents and trademarks in China and the Asia Pacific regions.PharmaPrint will retain title to the technologies.